World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
38186
World Ranking
11594
National Ranking
157

Overview

Lukas Bubendorf is affiliated with the University Hospital of Basel in Switzerland and has a substantial publication record in the field of medicine, with a focus on pulmonary and respiratory medicine, oncology, surgery, cancer research, and molecular biology. Their research spans various aspects of cancer diagnosis, treatment, and genomic analysis.

The scientist's main fields of study include:

  • Medicine

The primary subfields of their research are:

  • Pulmonary and Respiratory Medicine
  • Oncology
  • Surgery
  • Cancer Research
  • Molecular Biology

Lukas Bubendorf's work covers a range of topics connected to cancer and urogenital disease, including:

  • Lung Cancer Treatments and Mutations
  • Prostate Cancer Treatment and Research
  • Cancer Genomics and Diagnostics
  • Bladder and Urothelial Cancer Treatments
  • Prostate Cancer Diagnosis and Treatment
  • Lung Cancer Diagnosis and Treatment
  • Urinary and Genital Oncology Studies

Their recent papers include:

  • A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee, 2020, Journal of Thoracic Oncology
  • IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy, 2020, Journal of Thoracic Oncology
  • The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee, 2020, Journal of Thoracic Oncology
  • Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression, 2021, Nature Communications
  • Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. I. Molecular Biomarkers in Prostate Cancer, 2020, The American Journal of Surgical Pathology

Lukas Bubendorf has collaborated frequently with a group of co-authors, including:

  • Fernando Schmitt
  • Cyrill A. Rentsch
  • Deepali Jain
  • Zubair Baloch
  • Giancarlo Troncone

The scientist is also known for regular publications in several prominent journals, such as:

  • Cancer Cytopathology
  • Journal of Thoracic Oncology
  • Lung Cancer
  • Cancer Research
  • European Urology

Best Publications

  • Tissue microarrays for high-throughput molecular profiling of tumor specimens

    J Kononen;L Bubendorf;A Kallioniemi;M Bärlund

  • Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients.

    Lukas Bubendorf;Alain Schöpfer;Urs Wagner;Guido Sauter

  • Gene-Expression Profiles in Hereditary Breast Cancer

    I Hedenfalk;D Duggan;Y Chen;M Radmacher

  • Survey of Gene Amplifications during Prostate Cancer Progression by High-Throughput Fluorescence in Situ Hybridization on Tissue Microarrays

    Lukas Bubendorf;Juha Kononen;Pasi Koivisto;Peter Schraml

  • PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project.

    Ming Sound Tsao;Keith M. Kerr;Mark Kockx;Mary Beth Beasley

  • Tissue Microarrays for Gene Amplification Surveys in Many Different Tumor Types

    Peter Schraml;Juha Kononen;Lukas Bubendorf;Holger Moch

  • High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma.

    Holger Moch;Peter Schraml;Lukas Bubendorf;Martina Mirlacher

  • Loss of NKX3.1 Expression in Human Prostate Cancers Correlates with Tumor Progression1,2

    Cai Bowen;Lukas Bubendorf;H. James Voeller;Rebecca Slack

  • Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies.

    Lukas Bubendorf;Antonio Nocito;Holger Moch;Guido Sauter

  • 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

    J. Vansteenkiste;L. Crinò;C. Dooms;J. Y. Douillard

  • Hormone Therapy Failure in Human Prostate Cancer: Analysis by Complementary DNA and Tissue Microarrays

    Lukas Bubendorf;Meelis Kolmer;Meelis Kolmer;Juha Kononen;Pasi Koivisto

  • Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers.

    P Went;M Vasei;L Bubendorf;L Terracciano

  • 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer

    W.E.E. Eberhardt;D. De Ruysscher;W. Weder;C. Le Péchoux

  • Detecting Activation of Ribosomal Protein S6 Kinase by Complementary DNA and Tissue Microarray Analysis

    Maarit Bärlund;Farahnaz Forozan;Juha Kononen;Lukas Bubendorf

  • Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade.

    Antonio Nocito;Lukas Bubendorf;Eva Maria Tinner;Katrin Süess

  • Patterns of HER-2/neu Amplification and Overexpression in Primary and Metastatic Breast Cancer

    Ronald Simon;Antonio Nocito;Tanja Hübscher;Christoph Bucher

  • Elevated expression of inhibitor of apoptosis proteins in prostate cancer.

    Maryla Krajewska;Stan Krajewski;Steven Banares;Xianshu Huang

  • Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer

    Keith M. Kerr;Lukas Bubendorf;Martin J. Edelman;Antonio Marchetti

  • A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee.

    Andre L. Moreira;Paolo S.S. Ocampo;Yuhe Xia;Hua Zhong

  • Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer

    Yasushi Yatabe;Sanja Dacic;Alain C. Borczuk;Arne Warth

Frequent Co-Authors

Keith M. Kerr
Keith M. Kerr Aberdeen Royal Infirmary
Guido Sauter
Guido Sauter Universität Hamburg
Michael J. Mihatsch
Michael J. Mihatsch University Hospital of Basel
Solange Peters
Solange Peters University Hospital of Lausanne
Rolf A. Stahel
Rolf A. Stahel University of Zurich
Michael Tamm
Michael Tamm University Hospital of Basel
Holger Moch
Holger Moch University of Zurich
Inti Zlobec
Inti Zlobec University of Bern
Olli Kallioniemi
Olli Kallioniemi Karolinska Institute
Walter Weder
Walter Weder University of Zurich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always mean pursuing a traditional MD. Today’s healthcare landscape offers many online degree and certification options for those interested in supporting roles or management positions within the industry.

If you’re looking for a non-clinical option, consider medical coding and billing classes online with financial aid. These programs are flexible and can lead to quick entry into the healthcare workforce.

For those drawn to nursing, there are alternative pathways available. Some students prefer to enroll in a nursing school that does not require teas test, eliminating one common hurdle from the application process.

Ambitious professionals aiming for leadership roles may be interested in an accelerated healthcare administration degree online, designed to fast-track your career into the business side of medicine.

Finally, registered nurses can advance their expertise with rn to fnp bridge programs, moving towards becoming family nurse practitioners through streamlined online coursework.

Each of these pathways allows for flexibility, a variety of career options, and the convenience of online learning to help you achieve your goals in healthcare.

Best Scientists Citing Lukas Bubendorf

Trending Scientists